CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-01 | Napolitano Richard J Chief Accounting Officer | Option exercise | +2,019 | 2,019 | ||
| 2022-02-01 | Napolitano Richard J Chief Accounting Officer | Option exercise · Restricted Stock Units | −2,019 | 4,039 | ||
| 2022-01-10 | Trencher Daniel SVP Corporate Strategy | Option exercise | +2,000 | $22.30 | $45K | 25,486 |
| 2022-01-10 | Trencher Daniel SVP Corporate Strategy | Sale | −2,000 | $81.75 | $164K | 23,486 |
| 2022-01-10 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −2,000 | 13,430 | ||
| 2021-12-10 | Trencher Daniel SVP Corporate Strategy | Option exercise | +2,000 | $22.30 | $45K | 25,486 |
| 2021-12-10 | Trencher Daniel SVP Corporate Strategy | Sale | −2,000 | $95.77 | $192K | 23,486 |
| 2021-12-10 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −2,000 | 15,430 | ||
| 2021-11-26 | Geshuri Arnnon Chief Human Resources Officer | Sale | −3,664 | $116.08 | $425K | 85,781 |
| 2021-11-22 | Daniel Karen L Director | Sale | −109 | $115.33 | $13K | 42,242 |
| 2021-11-19 | Daniel Karen L Director | Option exercise | +436 | 42,351 | ||
| 2021-11-19 | Daniel Karen L Director | Option exercise · Restricted Stock Units | −436 | 872 | ||
| 2021-11-19 | Bischoff Christopher Director | Option exercise | +436 | 5,557 | ||
| 2021-11-19 | Bischoff Christopher Director | Option exercise · Restricted Stock Units | −436 | 872 | ||
| 2021-11-19 | Fenwick Sandra L Director | Option exercise | +436 | 11,198 | ||
| 2021-11-19 | Fenwick Sandra L Director | Option exercise · Restricted Stock Units | −436 | 872 | ||
| 2021-11-15 | Vandervoort Adam C Chief Legal Officer, Secretary | Sale | −2,000 | $136.00 | $272K | 2,000 |
| 2021-11-10 | Trencher Daniel SVP Corporate Strategy | Option exercise | +2,000 | $22.30 | $45K | 25,486 |
| 2021-11-10 | Trencher Daniel SVP Corporate Strategy | Sale | −2,000 | $140.18 | $280K | 23,486 |
| 2021-11-10 | Trencher Daniel SVP Corporate Strategy | Option exercise · Employee Stock Option (right to buy) | −2,000 | 17,430 |
Page 67 of 93 · 1,848 trades